Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 12:36 pm Sale |
2023-12-31 | 13G | Xometry, Inc. XMTR |
Eventide Asset Management, LLC | 5,727,770 12.620% |
-2,569 (-0.04%) |
Filing History |
| 2024-02-14 12:29 pm Sale |
2023-12-31 | 13G | VectivBio Holding AG VECT |
Eventide Asset Management, LLC | 0 0.000% |
-3,405,644 (Position Closed) |
Filing History |
| 2024-02-14 12:21 pm Unchanged |
2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 12:18 pm Purchase |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 4,529,997 8.300% |
1,379,997 (+43.81%) |
Filing History |
| 2024-02-14 12:15 pm Unchanged |
2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 12:04 pm Purchase |
2023-12-31 | 13G | Collegium Pharmaceutical, Inc. COLL |
Eventide Asset Management, LLC | 2,630,478 8.070% |
885 (+0.03%) |
Filing History |
| 2024-02-14 12:02 pm Sale |
2023-12-31 | 13G | 908 Devices Inc. MASS |
Eventide Asset Management, LLC | 1,430,995 4.420% |
-799,670 (-35.85%) |
Filing History |
| 2024-02-14 11:59 am Purchase |
2023-12-31 | 13G | Korro Bio, Inc. KRRO |
Eventide Asset Management, LLC | 546,325 6.830% |
546,325 (New Position) |
Filing History |
| 2024-02-14 11:54 am Purchase |
2023-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 3,179,837 5.150% |
3,179,837 (New Position) |
Filing History |
| 2024-02-14 11:48 am Purchase |
2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Eventide Asset Management, LLC | 3,630,013 6.640% |
3,630,013 (New Position) |
Filing History |
| 2023-12-11 5:15 pm Purchase |
2023-11-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 11,559,975 16.340% |
3,745,936 (+47.94%) |
Filing History |
| 2023-12-11 5:14 pm Purchase |
2023-11-30 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 5,802,682 11.820% |
3,551,314 (+157.74%) |
Filing History |
| 2023-12-11 5:13 pm Purchase |
2023-11-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 3,002,831 11.930% |
3,002,831 (New Position) |
Filing History |
| 2023-11-13 4:10 pm Purchase |
2023-11-01 | 13G | VYNE Therapeutics Inc. VYNE |
Eventide Asset Management, LLC | 1,394,336 9.990% |
1,394,336 (New Position) |
Filing History |
| 2023-11-13 2:43 pm Purchase |
2023-10-31 | 13G | Xometry, Inc. XMTR |
Eventide Asset Management, LLC | 5,730,339 12.650% |
5,730,339 (New Position) |
Filing History |
| 2023-10-10 3:40 pm Purchase |
2023-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 7,814,039 11.070% |
7,814,039 (New Position) |
Filing History |
| 2023-02-14 3:04 pm Unchanged |
2022-12-31 | 13G | Vital Farms, Inc. VITL |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 3:00 pm Sale |
2022-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Eventide Asset Management, LLC | 0 0.000% |
-2,708,975 (Position Closed) |
Filing History |
| 2023-02-14 2:50 pm Sale |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Eventide Asset Management, LLC | 0 0.000% |
-3,318,647 (Position Closed) |
Filing History |
| 2023-02-14 2:37 pm Unchanged |
2022-12-31 | 13G | Zymeworks Inc. ZYME |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |